CAH CAH カ―ディナルヘルス

Cardinal Health (CAH) is scheduled to announce Q3 earnings results on Thursday, May 4th, before market open.The consensus EPS Estimate is $1.49 (+24.2% Y/Y) and the consensus Revenue…

Buying dividend aristocrats is a reasonable strategy for those investors seeking long-term income. The equities in this group have paid increasing dividends for the past 25+ years, so they will likely continue to provide passive income for the foreseeable future. It’s a pretty select group, consisting of 68 publicly traded companies, all of which are in the S&P 500 . So, that’s arguably the 68 best firms among the 500 largest publicly traded companies in the United States. But we’re being even more selective here. I’d argue favor investing in dividend aristocrats within three sectors: energy, consumer staples, and healthcare. These are widely predicted to be the best-performing sectors this year, and a strong argument for that case remains. CVX Chevron $168.09 XOM Exxon Mobil $118.45 NEE NextEra Energy $76.38 KO Coca-Cola $63.81 WMT Walmart $150.42 WST West Pharmaceutical Services $363.34 CAH Cardinal Health $81.85 Chevron (CVX) Source: tishomir / Shutterstock.com Chevron (NYSE: CVX ) is one of two energy stocks counted among this list of top dividend aristocrats.

SAN FRANCISCO, CA / ACCESSWIRE / April 28, 2023 / Chronicled, the custodian of the MediLedger Network, announces the appointment of Vinod Lakhani as its new Chief Executive Officer. Vinod succeeds Susanne Somerville, who will step down as CEO and remain as an advisor to the company. Vinod Lakhani MediLedger is a blockchain-based network that creates industry-wide alignment, accuracy, and dispute settlement in life sciences and medical-surgical industries, recapturing lost revenue and optimizing gross-to-net savings. Current network members include AmerisourceBergen, Cardinal Health, Amici Pharmaceuticals, Fortune 500 manufacturers, and a number of other manufacturers, wholesaler, and group purchasing organizations. Vinod Lakhani brings an extensive background in product management, operations, and emerging technology to his new role. With a passion for building businesses, leading innovation, and driving growth, Lakhani has played a pivotal role in launching products and teams that have generated over $1 billion in revenue.

Cardinal Health, Inc. (NYSE:CAH – Get Rating) reached a new 52-week high during mid-day trading on Thursday after Deutsche Bank Aktiengesellschaft raised their price target on the stock from $77.00 to $88.00. The stock traded as high as $81.82 and last traded at $81.74, with a volume of 757797 shares. The stock had previously closed […]

Cardinal Health (CAH) achieved a new 52-week high of $81.82 on Thursday. The drugs distributor is up ~7% year to date and ~37% over the last year. Read more here.

Cardinal Health press release (CAH): Q2 Non-GAAP EPS of $1.27 beats by $0.04.Revenue of $45.46B (+9.4% Y/Y) beats by $140M.The company updated its fiscal year 2022 guidance range

Cardinal Health (NYSE:CAH) is scheduled to announce Q2 earnings results on Thursday, February 3rd, before market open.The consensus EPS Estimate is $1.23 (-29.3% Y/Y) and the

Johnson & Johnson and the country''s three major drug distributors agreed Tuesday to pay $590 million to Native American tribes affected by the opioid crisis, according to a proposed settlement . Why it matters: It''s the largest opioid settlement for Native Americans, the Washington Post notes. "American Indians have suffered the highest per capita rate of opioid overdose and are more likely than other group in the United States to die from drug-induced deaths," said Douglas Yankton, chair of the Spirit Lake Nation in North Dakota, in a statement, per AP . "The dollars that will flow to Tribes under this initial settlement will help fund crucial, on-reservation, culturally appropriate opioid treatment services," Yankton added. The big picture: More than 400 tribes sued the companies, alleging that they helped fuel abuse of the addictive painkillers, Bloomberg reports. By the numbers: In Tuesday''s settlement, distributors McKesson, Cardinal Health and AmerisourceBergen have agreed to pay $440 million over seven years to tribes that have been disproportionately impacted by the opioid crisis.

Drug distributor Cardinal Health Inc has agreed to pay more than $13 million to resolve allegations that it paid doctors kickbacks to purchase specialty pharmaceutical products from it rather than rivals, the U.S. Justice Department said on Monday.

Price T Rowe Associates Inc. MD increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 34.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,984,778 shares of the companys stock after buying an additional 3,338,519 shares during the quarter. Price T []

Related Stocks: JPEM , FIS , ADI , NKE , MRNA , PAG , CTVA , GE , SPOT , CAH , PNW , NXPI ,

Cardinal Health, Inc. (NYSE:CAH) announced a quarterly dividend on Thursday, November 4th, RTT News reports. Stockholders of record on Monday, January 3rd will be paid a dividend of 0.4908 per share on Saturday, January 15th. This represents a $1.96 dividend on an annualized basis and a dividend yield of 3.99%. Cardinal Health has increased its []

DUBLIN, Ohio, Nov. 4, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of record at the close of business on January 3, 2022.

DUBLIN, Ohio, Nov. 4, 2021 /PRNewswire/ -- Biologics are the fastest growing class of drugs in the U.S.; they bring innovative, life-changing treatments to patients with cancer and chronic diseases. Due to exclusive patents, they are also very expensive and out of reach for many. When